Synthetic Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYN and buy or sell other stocks, ETFs, and their options commission-free!About SYN
Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004.
CEOSteven A. Shallcross, MBA, CPA
CEOSteven A. Shallcross, MBA, CPA
Employees22
Employees22
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2001
Founded2001
Employees22
Employees22
SYN Key Statistics
Market cap1.37M
Market cap1.37M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume5.27M
Average volume5.27M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.75
52 Week high$10.75
52 Week low$0.47
52 Week low$0.47
Stock Snapshot
The current Synthetic Biologics(SYN) stock price is $0.49, with a market capitalization of 1.37M. The stock trades at a price-to-earnings (P/E) ratio of -0.03.
On 2025-12-22, Synthetic Biologics(SYN) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 5.27M.
The stock's 52-week range extends from a low of $0.47 to a high of $10.75.
The stock's 52-week range extends from a low of $0.47 to a high of $10.75.